Gut microbiota metabolizes nabumetone in vitro: Consequences for its bioavailability in vivo in the rodents with altered gut microbiome

References

• Al-Hilal TA, Alam F, Byun Y. (2013). Oral drug delivery systems using chemical conjugates or physical complexes. Adv drug deliv Rev 65:845–64.
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ley RE, Sonnenburg JL, et al. (2005). Host-bacterial mutualism in the human intestine. Science 307:1915–20.
   PubMed Web of Science ®Google Scholar
• Consortium HMP. (2012). Structure, function and diversity of the healthy human microbiome. Nature 486:207–14.
   PubMed Web of Science ®Google Scholar
• De La Cochetiere MF, Durand T, Lepage P, et al. (2005). Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J clin Microbio 43:5588–92.
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Relman DA. (2011). Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Nat Acad Sci USA 108 Suppl 1:4554–61.
   PubMed Web of Science ®Google Scholar
• Friedel HA, Langtry HD, Buckley MM. (1993). Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases. Drugs 45:131–56.
   PubMed Web of Science ®Google Scholar
• Gill SR, Pop M, Deboy RT, et al. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312:1355–9.
   PubMed Web of Science ®Google Scholar
• Haiser HJ, Turnbaugh PJ. (2013). Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res 69:21–31.
   PubMed Web of Science ®Google Scholar
• Hedner T, Samulesson O, Wahrborg P, et al. (2004). Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis. Drugs 64:2315–43.
   PubMed Web of Science ®Google Scholar
• Jernberg C, Löfmark S, Edlund C, Jansson JK. (2007). Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1:56–66.
   PubMed Web of Science ®Google Scholar
• Jourova L, Anzenbacher P, Anzenbacherova E. (2016). Human gut microbiota plays a role in the metabolism of drugs. Biomed pap Med Fac Univ Palacky Olomouc Czech Repub 160:317–26.
   PubMed Web of Science ®Google Scholar
• Jourova L, Anzenbacher P, Liskova B, et al. (2017). Colonization by non-pathogenic bacteria alters mRNA expression of cytochromes P450 in originally germ-free mice. Folia Microbiologica 62:463–9.
   PubMed Web of Science ®Google Scholar
• Kang MJ, Kim HG, Kim JS, et al. (2013). The effect of gut microbiota on drug metabolism. Expert Opin Drug Metab Toxicol 9:1295–308.
   PubMed Web of Science ®Google Scholar
• Kim DH. (2015). Gut microbiota-mediated drug-antibiotic interactions. Drug metab dispos 43:1581–9.
   PubMed Web of Science ®Google Scholar
• Kinross JM, Darzi AW, Nicholson JK. (2011). Gut microbiome-host interactions in health and disease. Genome Med 3:14.
   PubMed Web of Science ®Google Scholar
• Kverka M, Zakostelska Z, Klimesova K, et al. (2011). Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 163:250–9.
   PubMed Web of Science ®Google Scholar
• Li H, He J, Jia W. (2016). The influence of gut microbiota on drug metabolism and toxicity. Exp Opin Drug Metab Toxicol 12:31–40.
   PubMed Web of Science ®Google Scholar
• Manichanh C, Reeder J, Gibert P, et al. (2010). Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 20:1411–9.
   PubMed Web of Science ®Google Scholar
• Matuskova Z, Anzenbacher P, Vecera R, et al. (2017). Effect of Lactobacillus casei on the pharmacokinetics of amiodarone in male Wistar rats. Eur J Drug Metab Pharmacokinet 42:29–36.
   PubMed Web of Science ®Google Scholar
• Matuskova Z, Anzenbacherova E, Vecera R, et al. (2014). Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats. PloS One 9:e87150.
   PubMed Web of Science ®Google Scholar
• Maurice CF, Haiser HJ, Turnbaugh PJ. (2013). Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152:39–50.
   PubMed Web of Science ®Google Scholar
• Mikov M. (1994). The metabolism of drugs by the gut flora. Eur J Drug Metab Pharmacokinet 19:201–7.
   PubMed Web of Science ®Google Scholar
• Neely MN, van Guilder MG, Yamada WM, et al. (2012). Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R. Therap drug Monitor 34:467–76.
   PubMed Web of Science ®Google Scholar
• Nobilis M, Mikusek J, Szotakova B, et al. (2013). Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites. J Pharma Biomed Anal 80:164–72.
   PubMed Web of Science ®Google Scholar
• Nobilis M, Kopecký J, Kvetina J, et al. (2003). Comparative biotransformation and disposition studies of nabumetone in humans and minipigs using high-performance liquid chromatography with ultraviolet, fluorescence and mass spectrometric detection. J Pharma Biomed Anal 32:641–56.
   PubMed Web of Science ®Google Scholar
• O'Hara AM, Shanahan F. (2006). The gut flora as a forgotten organ. EMBO Rep 7:688–93.
   PubMed Web of Science ®Google Scholar
• Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, et al. (2013). Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62:1591–601.
   PubMed Web of Science ®Google Scholar
• Pickard JM, Zeng MY, Caruso R, Núñez G. (2017). Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immuno Rev 279:70–89.
   PubMed Web of Science ®Google Scholar
• Saad R, Rizkallah MR, Aziz RK. (2012). Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes. Gut Pathogens 4:16.
   PubMed Web of Science ®Google Scholar
• Scheline RR. (1968). Drug metabolism by intestinal microorganisms. J Pharm Sci 57:2021–37.
   PubMed Web of Science ®Google Scholar
• Scott KP, Gratz SW, Sheridan PO, et al. (2013). The influence of diet on the gut microbiota. Pharmacol Res 69:52–60.
   PubMed Web of Science ®Google Scholar
• Shamat MA. (1993). The role of the gastrointestinal microflora in the metabolism of drugs. Int J Pharma 97:1–13.
   Web of Science ®Google Scholar
• Sousa T, Paterson R, Moore V, et al. (2008). The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm 363:1–25.
   PubMed Web of Science ®Google Scholar
• Stojančević M, Bojić G, Al-Salami H, Mikov M. (2013). The influence of intestinal tract and probiotics on the fate of orally administered drugs. Curr Issues Mol Biol 4:2.
   Google Scholar
• Yoo DH, Kim IS, Van Le TK, et al. (2014). Gut microbiota-mediated drug interactions between lovastatin and antibiotics. Drug Metab Dispos 42:1508–13.
   PubMed Web of Science ®Google Scholar